Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Juan Li"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Upregulation of PITX2 Promotes Letrozole Resistance Via Transcriptional Activation of IFITM1 Signaling in Breast Cancer Cells
Ying-ying Xu, Hai-ru Yu, Jia-yi Sun, Zhao Zhao, Shuang Li, Xin-feng Zhang, Zhi-xuan Liao, Ming-ke Cui, Juan Li, Chan Li, Qiang Zhang
Cancer Res Treat. 2019;51(2):576-592.   Published online July 18, 2018
DOI: https://doi.org/10.4143/crt.2018.100
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Although the interferon α (IFNα) signaling and the paired-like homeodomain transcription factor 2 (PITX2) have both been implicated in the progression of breast cancer (BCa), it remains obscure whether these two pathways act in a coordinated manner. We therefore aimed to elucidate the expression and function of PITX2 during the pathogenesis of endocrine resistance in BCa.
Materials and Methods
PITX2 expression was assessed in BCa tissues using quantitative reverse transcription polymerase chain reaction (RT-qPCR) and immunohistochemistry and in experimentally induced letrozole-resistant BCa cells using RT-qPCR and immunoblotting. Effects of PITX2 deregulation on BCa progression was determined by assessing MTT, apoptosis and xenograft model. Finally, using multiple assays, the transcriptional regulation of interferon-inducible transmembrane protein 1 (IFITM1) by PITX2 was studied at both molecular and functional levels.
Results
PITX2 expression was induced in letrozole-resistant BCa tissues and cells, and PITX2 induction by IFNα signaling powerfully protected BCa cells against letrozole insult and potentiated letrozole-resistance. Mechanistically, PITX2 enhanced IFNα-induced AKT activation by transactivating the transcription of IFITM1, thus rendering BCa cells unresponsive to letrozoleelicited cell death. Additionally, ablation of IFITM1 expression using siRNA substantially abolished IFNα-elicited AKT phosphorylation, even in the presence of PITX2 overexpression, thus sensitizing BCa cells to letrozole treatment.
Conclusion
These results demonstrate that constitutive upregulation of PITX2/IFITM1 cascade is an intrinsic adaptive mechanism during the pathogenesis of letrozole-resistance, and modulation of PITX2/IFITM1 level using different genetic and pharmacological means would thus have a novel therapeutic potential against letrozole resistance in BCa.

Citations

Citations to this article as recorded by  
  • Proteomic profiling of ovarian clear cell carcinomas identifies prognostic biomarkers for chemotherapy
    Liang Yue, Tingting Gong, Wenhao Jiang, Liujia Qian, Wangang Gong, Yaoting Sun, Xue Cai, Heli Xu, Fanghua Liu, He Wang, Sainan Li, Yi Zhu, Zhiguo Zheng, Qijun Wu, Tiannan Guo
    PROTEOMICS.2024;[Epub]     CrossRef
  • The role and mechanism of IFITM1 in developing acquired cisplatin resistance in small cell lung cancer
    Xuemei Wang, Haihong Qian, Ling Yang, Shuangli Yan, Hua Wang, Xiu Li, Donghai Yang
    Heliyon.2024; 10(10): e30806.     CrossRef
  • PITX2 functions as a transcription factor for GPX4 and protects pancreatic cancer cells from ferroptosis
    Zhiliang Wang, Di Wu, Yue Zhang, Weibo Chen, Yang Yang, Yue Yang, Guangchen Zu, Yong An, Xianjun Yu, Yi Qin, Xiaowu Xu, Xuemin Chen
    Experimental Cell Research.2024; 439(1): 114074.     CrossRef
  • Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function by inducing apoptosis in a rat model of experimental autoimmune prostatitis
    Qi Gu, Jiaochen Luan, Mengchi Yu, Jiadong Xia, Zengjun Wang
    International Journal of Impotence Research.2024;[Epub]     CrossRef
  • Unveiling stem-like traits and chemoresistance mechanisms in ovarian cancer cells through the TGFβ1-PITX2A/B signaling axis
    Sampurna Ghosh, Sk. Eashayan Tanbir, Tulika Mitra, Sib Sankar Roy
    Biochemistry and Cell Biology.2024;[Epub]     CrossRef
  • Oncogene‐mediated nuclear accumulation of lactate promotes epigenetic alterations to induce cancer cell proliferation
    Shreya Bandopadhyay, Izaz M. Kamal, E. Padmanaban, Damayanti D. Ghosh, Saikat Chakrabarti, Sib S. Roy
    Journal of Cellular Biochemistry.2023; 124(4): 495.     CrossRef
  • Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis
    Chenlu Wu, Jiafei Ying, Mei Dai, Jing Peng, Danhua Zhang
    Journal of Cancer Research and Clinical Oncology.2022; 148(12): 3385.     CrossRef
  • MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells
    Zining Liu, Weili Zhang, Biao Zhang, Shaomu Chen, Chunhua Ling
    Genetic Testing and Molecular Biomarkers.2022; 26(7-8): 351.     CrossRef
  • Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression
    Olivia K. Provance, Eric S. Geanes, Asona J. Lui, Anuradha Roy, Sean M. Holloran, Sumedha Gunewardena, Christy R. Hagan, Scott Weir, Joan Lewis-Wambi
    Cancer Letters.2021; 514: 12.     CrossRef
  • The significance of homeodomain transcription factor 2 in colon cancer cells
    Yang He, Peng Gong, Sitong Wang, Qing Xu, Jianhua Chen
    BioMedical Engineering OnLine.2021;[Epub]     CrossRef
  • Forkhead-box A3 (FOXA3) Represses Cancer Stemness and Partially Potentiates Chemosensitivity by Targeting Metastasis-Associated in Colon Cancer 1 (MACC1) Signaling Pathway in Colorectal Cancer Cells
    Na Li, Yun Li, Hongbo Gao, Jing Li, Xiaoping Ma, Xiaomei Liu, Ping Gong, Xiaobin Cui, Yong Li
    Current Cancer Drug Targets.2021; 21(3): 254.     CrossRef
  • PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients
    Rudolf Napieralski, Gabriele Schricker, Gert Auer, Michaela Aubele, Jonathan Perkins, Viktor Magdolen, Kurt Ulm, Moritz Hamann, Axel Walch, Wilko Weichert, Marion Kiechle, Olaf G. Wilhelm
    Breast Care.2021; 16(5): 523.     CrossRef
  • Downregulation of PITX2 inhibits the proliferation and migration of liver cancer cells and induces cell apoptosis
    Kebinuer Tuerxun, Shufang Zhang, Yuexin Zhang
    Open Life Sciences.2021; 16(1): 1322.     CrossRef
  • Deciphering the Roles of IFITM1 in Tumors
    Renba Liang, Xinxiao Li, Xiaodong Zhu
    Molecular Diagnosis & Therapy.2020; 24(4): 433.     CrossRef
  • Interferon-induced transmembrane protein 1 (IFITM1) is essential for progression of laryngeal squamous cell carcinoma in an Osteopontin/NF-κB-dependent manner
    Yong Yin, Keke Yang, Juanjuan Li, Peng Da, Zhenxin Zhang, Xiaoxia Qiu
    Cancer Biomarkers.2020; 29(4): 521.     CrossRef
  • DNA Methylation Events in Transcription Factors and Gene Expression Changes in Colon Cancer
    Anna Díez-Villanueva, Rebeca Sanz-Pamplona, Robert Carreras-Torres, Ferran Moratalla-Navarro, M Henar Alonso, Laia Paré-Brunet, Susanna Aussó, Elisabet Guinó, Xavier Solé, David Cordero, Ramón Salazar, Maria Berdasco, Miguel A Peinado, Victor Moreno
    Epigenomics.2020; 12(18): 1593.     CrossRef
  • PITX2 enhances progression of lung adenocarcinoma by transcriptionally regulating WNT3A and activating Wnt/β-catenin signaling pathway
    Jing Luo, Yu Yao, Saiguang Ji, Qi Sun, Yang Xu, Kaichao Liu, Qiang Diao, Yong Qiang, Yi Shen
    Cancer Cell International.2019;[Epub]     CrossRef
  • 9,705 View
  • 234 Download
  • 21 Web of Science
  • 17 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP